These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25742214)

  • 41. Acamprosate in the treatment of alcohol dependence: clinical and economic considerations.
    Mason BJ; Crean R
    Expert Rev Neurother; 2007 Nov; 7(11):1465-77. PubMed ID: 17997696
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Reports from the Federal Conference of German Psychiatry and Psychotherapy Clinics].
    Längle G; Pollmächer T
    Psychiatr Prax; 2013 Apr; 40(3):164-5. PubMed ID: 23559448
    [No Abstract]   [Full Text] [Related]  

  • 43. Body and behavioral experiences in recovery from alcoholism.
    Hoffman AL; Estes NJ
    Rehabil Nurs; 1987; 12(4):188-92, 187. PubMed ID: 3650924
    [No Abstract]   [Full Text] [Related]  

  • 44. A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal.
    Mariani JJ; Rosenthal RN; Tross S; Singh P; Anand OP
    Am J Addict; 2006; 15(1):76-84. PubMed ID: 16449096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Production of reactive oxygen species following acute ethanol or acetaldehyde and its reduction by acamprosate in chronically alcoholized rats.
    Dahchour A; Lallemand F; Ward RJ; De Witte P
    Eur J Pharmacol; 2005 Sep; 520(1-3):51-8. PubMed ID: 16135364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful implementation of an alcohol-withdrawal pathway in a general hospital.
    Repper-DeLisi J; Stern TA; Mitchell M; Lussier-Cushing M; Lakatos B; Fricchione GL; Quinlan J; Kane M; Berube R; Blais M; Capasso V; Pathan F; Karson A; Bierer M
    Psychosomatics; 2008; 49(4):292-9. PubMed ID: 18621934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Adjuvant drug treatment of alcoholism with acamprosate: between sectoral budgets and disease management].
    Rychlik R; Paschen B; Kirchhoff D; Daniel D; Pfeil T; Kilburg A
    Dtsch Med Wochenschr; 2001 Aug; 126(33):899-904. PubMed ID: 11514924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pharmacological treatment of alcohol dependence: needs and possibilities.
    Mann K
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():55-8. PubMed ID: 8737001
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The administration of transcranial electric treatment for affective disturbances therapy in alcoholic patients.
    Krupitsky EM; Burakov AM; Karandashova GF; Katsnelson JaS ; Lebedev VP; Grinenko AJa ; Borodkin JuS
    Drug Alcohol Depend; 1991 Jan; 27(1):1-6. PubMed ID: 2029855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies.
    Lejoyeux M; Lehert P
    Alcohol Alcohol; 2011; 46(1):61-7. PubMed ID: 21118900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Efficient prevention of relapse with acamprosate].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2000 Jun; 23(6):206-7. PubMed ID: 10950666
    [No Abstract]   [Full Text] [Related]  

  • 52. Alcoholism, anxiety, and opioid-dopaminergic interactions.
    Sher L
    Psychopharmacology (Berl); 2003 Jan; 165(2):202-3. PubMed ID: 12428151
    [No Abstract]   [Full Text] [Related]  

  • 53. [Cue-induced alcohol craving. Neurobiological correlates and clinical relevance].
    Wrase J; Grüsser SM; Heinz A
    Nervenarzt; 2006 Sep; 77(9):1051-2, 1055-8, 1060-3. PubMed ID: 16534643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Temporal orientation and a course of alcohol addiction therapy].
    Chodkiewicz J; Nowakowska K
    Psychiatr Pol; 2011; 45(2):177-86. PubMed ID: 21714207
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of the alcohol withdrawal syndrome: a new approach, part 2.
    Talbott GD
    Md State Med J; 1976 Jul; 25(7):30-2. PubMed ID: 957795
    [No Abstract]   [Full Text] [Related]  

  • 56. [Outpatient clinic--therapy of withdrawal state, rehabilitation of patients with alcoholism].
    Kosugi Y
    Nihon Rinsho; 1997 Feb; 55 Suppl():422-6. PubMed ID: 9078767
    [No Abstract]   [Full Text] [Related]  

  • 57. Delirium following cessation of alcohol consumption.
    Fink M
    Am J Psychiatry; 1998 Nov; 155(11):1638-9. PubMed ID: 9812149
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of acamprosate on attentional set-shifting and cellular function in the prefrontal cortex of chronic alcohol-exposed mice.
    Hu W; Morris B; Carrasco A; Kroener S
    Alcohol Clin Exp Res; 2015 Jun; 39(6):953-61. PubMed ID: 25903298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nifedapine for protracted withdrawal syndrome.
    Katta BB
    Can J Psychiatry; 1991 Mar; 36(2):155. PubMed ID: 2044037
    [No Abstract]   [Full Text] [Related]  

  • 60. What makes alcohol-dependent individuals early in abstinence crave for alcohol: exposure to the drink, images of drinking, or remembrance of drinks past?
    Weinstein A; Lingford-Hughes A; Martinez-Raga J; Marshall J
    Alcohol Clin Exp Res; 1998 Sep; 22(6):1376-81. PubMed ID: 9756056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.